28 Jun 2021 | 02:23 pm |
Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.
The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.
The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.
Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.
The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).
Commenting on the transaction, Dr Susanne Lenz said:
"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."
Multinational law firm Pinsent Masons has announced today that it has been named as a supplier on Crown Commercial Service’s Legal Panel for Government framework on Lot 2- Major Project and Complex Advice.
Multinational law firm Pinsent Masons has advised Great British Energy (“GBE”), the National Wealth Fund (“NWF”) and the Scottish National Investment Bank (“SNIB”) on their acquisition of a stake in Pentland Offshore Wind Farm from Copenhagen Infrastructure Partners (“CIP”) and agreed to provide an aggregate investment of up to £150,000,000 in the project.
Multinational law firm Pinsent Masons has advised Swiss-based Ufenau Capital Partners on its investment in Express Solicitors, a fast-growing UK personal injury law firm.
Multinational law firm Pinsent Masons has advised on the recommended public takeover of AIM-listed Idox plc (Idox) by Frankel Bidco Limited, a vehicle that is indirectly owned by funds managed by Long Path Partners.
Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC), the largest global development institution focused on the private sector in emerging markets, on its first ever investment in Bhutan’s energy and infrastructure sectors.
Multinational law firm Pinsent Masons has today unveiled its unaudited financial results for the year ending 30 April 2025. This year's results have delivered a revenue increase of 4.7% after a year of continued growth within the firm’s core sectors and across its jurisdictions.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
